Israel's Ministry of Finance has issued an order extending the scope of intellectual property eligible for the country's intellectual property (IP) regime, which was introduced in 2017 and follows the modified nexus approach of BEPS Action 5 ({News-2017-05-26/A/4-previous coverage}). The order amends the definition of qualifying IP to provide that pharmaceutical products may qualify for the regime as long as they are registered, without the need to be patented. This includes products register…